Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • chouech
    Junior Member
    • Jul 2014
    • 2

    #1

    differential expression analysis for low coverage datasets

    Hi,

    I have RNAseq data with 1.5 M reads. But the general transcriptome coverge is very low. The percentage of gene covered over 70% at a given expression level is 20% only!

    So I was thinking that for differential expression analysis I'll get low power because I've got a lot of gene with low coverage that may be false positive...

    Do you think it could be a good idea to keep for differential analysis only gene with a moderate coverage like at least 50%??

    When I do this I can found more differentially expressed gene! (7 instead of 2)

    If someone has an opinion on this...
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    1) It would be helpful to know what organism you're using.
    2) Regardless, 1.5M reads very low for a good DE experiment in anything larger than a bacteria (and low even for a bacteria). It would only be informative about a handful of genes. And your 'coverage' metric is less useful than knowing the total number of reads mapped to a gene.

    It sounds to me like you should generate a lot more data if you want useful results.

    Comment

    • chouech
      Junior Member
      • Jul 2014
      • 2

      #3
      It's a fungal genome: Magnaporthe (40 Mbp) but I can't sequence more data... so I was thinking to try to do with what I have analysing only genes that have enough mapped reads... the problem is to choose a threshold. That's why I was thinking to keep only gene that are 50% covered at least... but that's true that is some part of the gene that may represent only 1 read!

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...